Tech Company Financing Transactions
Santa Maria Biotherapeutics Funding Round
Santa Maria Biotherapeutics, based in Brisbane, scored $18 million in funding from Amgen Ventures, Domain Associates and Kleiner Perkins Caufield & Byers.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$17,999,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3260 Bayshore Blvd.
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Email Address
Not Recorded
Overview
Santa Maria Biotherapeutics, Inc develops therapies for ovarian cancer that simultaneously reduce tumor burden and mitigate cachexia. Santa Maria Biotherapeutics, Inc is based in the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Isaac Ciechanover
Browse more venture capital transactions:
Prev: 12/31/2013: Ethical Electric venture capital transaction
Next: 12/31/2013: Sherlock Data Science venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs